IL114655A - USE OF GnRH ANTAGONIST IN THE MANUFACTURE OF A MEDICAMENT FOR THE TREATMENT OF A GONADAL-STEROID DEPENDENT CONDITION IN A MAMMAL - Google Patents

USE OF GnRH ANTAGONIST IN THE MANUFACTURE OF A MEDICAMENT FOR THE TREATMENT OF A GONADAL-STEROID DEPENDENT CONDITION IN A MAMMAL

Info

Publication number
IL114655A
IL114655A IL11465595A IL11465595A IL114655A IL 114655 A IL114655 A IL 114655A IL 11465595 A IL11465595 A IL 11465595A IL 11465595 A IL11465595 A IL 11465595A IL 114655 A IL114655 A IL 114655A
Authority
IL
Israel
Prior art keywords
gonadal
mammal
medicament
manufacture
treatment
Prior art date
Application number
IL11465595A
Other languages
English (en)
Other versions
IL114655A0 (en
Original Assignee
Hampton Roads Medical College
Ortho Pharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26959766&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL114655(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US08/467,860 external-priority patent/US5658884A/en
Application filed by Hampton Roads Medical College, Ortho Pharma Corp filed Critical Hampton Roads Medical College
Publication of IL114655A0 publication Critical patent/IL114655A0/xx
Publication of IL114655A publication Critical patent/IL114655A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Urology & Nephrology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Steroid Compounds (AREA)
IL11465595A 1994-07-22 1995-07-18 USE OF GnRH ANTAGONIST IN THE MANUFACTURE OF A MEDICAMENT FOR THE TREATMENT OF A GONADAL-STEROID DEPENDENT CONDITION IN A MAMMAL IL114655A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US27959394A 1994-07-22 1994-07-22
US08/467,860 US5658884A (en) 1994-07-22 1995-06-06 Establishment of tonic ovarian estrogen secretion for extended therapeutic regimens

Publications (2)

Publication Number Publication Date
IL114655A0 IL114655A0 (en) 1995-11-27
IL114655A true IL114655A (en) 2005-08-31

Family

ID=26959766

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11465595A IL114655A (en) 1994-07-22 1995-07-18 USE OF GnRH ANTAGONIST IN THE MANUFACTURE OF A MEDICAMENT FOR THE TREATMENT OF A GONADAL-STEROID DEPENDENT CONDITION IN A MAMMAL

Country Status (29)

Country Link
EP (1) EP0769956B1 (de)
JP (1) JP3138477B2 (de)
CN (1) CN1137722C (de)
AP (1) AP775A (de)
AT (1) ATE190494T1 (de)
AU (1) AU691952B2 (de)
BG (1) BG63363B1 (de)
BR (1) BR9508718A (de)
CA (1) CA2195745C (de)
CY (1) CY2228B1 (de)
CZ (1) CZ291803B6 (de)
DE (1) DE69515666T2 (de)
DK (1) DK0769956T3 (de)
EE (1) EE03515B1 (de)
ES (1) ES2145286T3 (de)
FI (1) FI970244L (de)
GR (1) GR3033590T3 (de)
HU (1) HU218910B (de)
IL (1) IL114655A (de)
IS (1) IS4413A (de)
LV (1) LV11823B (de)
MX (1) MX9700574A (de)
NO (1) NO970257D0 (de)
NZ (1) NZ290554A (de)
OA (1) OA10730A (de)
PT (1) PT769956E (de)
RU (1) RU2181598C2 (de)
SK (1) SK282118B6 (de)
WO (1) WO1996003138A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8173592B1 (en) 1999-03-31 2012-05-08 Zentaris Ivf Gmbh Method for a programmed controlled ovarian stimulation protocol
PL201898B1 (pl) * 1999-09-23 2009-05-29 Zentaris Gmbh Zastosowanie antagonisty LH-RH w leczeniu endometriozy
DE10137174A1 (de) * 2001-07-31 2003-02-13 Zentaris Ag Verwendung von LHRH-Antagonisten in nichtkastrierenden Dosen zur Verbesserung der T-Zellen-vermittelten Immunität
GB0616111D0 (en) * 2006-06-16 2006-09-20 Ardana Bioscience Ltd Agents, methods and uses
EP2095818A1 (de) 2008-02-29 2009-09-02 AEterna Zentaris GmbH Verwendung von LHRH-Antagonisten in nicht-kastrierenden Dosen
EP2307040B1 (de) * 2008-05-29 2015-09-09 Isr Immune System Regulation Ab Gnrh und sexhormone zur behandlung von viruserkrankungen, insbesondere hiv/aids
AU2016264034B2 (en) * 2015-05-18 2020-03-05 KaNDy Therapeutics Limited Dual NK-1/NK-3 receptor antagonists for the treatment of sex-hormone-dependent diseases
EA202092131A1 (ru) 2018-03-14 2020-11-27 Кэнди Терапьютикс Лимитед Новый фармацевтический препарат, содержащий двойные антагонисты рецептора nk-1/nk-3
EP3560555A1 (de) 2018-04-26 2019-10-30 LifeArc Zusammensetzung zur behandlung einer oder mehrerer östrogenvermittelter krankheiten
US12533358B1 (en) 2025-05-14 2026-01-27 Bayer Consumer Care Ag Methods of treatment with elinzanetant

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5171835A (en) * 1988-10-21 1992-12-15 The Administrators Of The Tulane Educational Fund LHRH antagonists
US5169932A (en) * 1989-10-30 1992-12-08 The Salk Institute For Biological Studies Gnrh analogs
US5211952A (en) * 1991-04-12 1993-05-18 University Of Southern California Contraceptive methods and formulations for use therein
ZA924811B (en) * 1991-06-28 1993-12-29 Endorecherche Inc Controlled release systems and low dose androgens
US5681817A (en) * 1994-02-04 1997-10-28 The Medical College Of Hampton Roads Treatment of ovarian estrogen dependent conditions
US5407955A (en) * 1994-02-18 1995-04-18 Eli Lilly And Company Methods for lowering serum cholesterol and inhibiting smooth muscle cell proliferation, restenosis, endometriosis, and uterine fibroid disease

Also Published As

Publication number Publication date
CY2228B1 (en) 2003-04-18
IL114655A0 (en) 1995-11-27
FI970244A0 (fi) 1997-01-21
JP3138477B2 (ja) 2001-02-26
WO1996003138A1 (en) 1996-02-08
NZ290554A (en) 2000-08-25
PT769956E (pt) 2000-07-31
BG101158A (bg) 1997-09-30
SK7097A3 (en) 1997-11-05
EP0769956A4 (de) 1999-03-10
GR3033590T3 (en) 2000-09-29
AP775A (en) 1999-10-28
JPH10503203A (ja) 1998-03-24
FI970244A7 (fi) 1997-01-21
AU691952B2 (en) 1998-05-28
DE69515666T2 (de) 2000-07-06
CN1200674A (zh) 1998-12-02
BR9508718A (pt) 1997-12-30
ES2145286T3 (es) 2000-07-01
NO970257L (no) 1997-01-21
MX9700574A (es) 1997-12-31
OA10730A (en) 2001-06-07
ATE190494T1 (de) 2000-04-15
SK282118B6 (sk) 2001-11-06
FI970244L (fi) 1997-01-21
NO970257D0 (no) 1997-01-21
CN1137722C (zh) 2004-02-11
LV11823B (en) 1998-03-20
LV11823A (lv) 1997-08-20
HUT77127A (hu) 1998-03-02
AU3132095A (en) 1996-02-22
CA2195745C (en) 2005-03-29
CZ15097A3 (en) 1997-11-12
IS4413A (is) 1997-01-14
DE69515666D1 (de) 2000-04-20
CZ291803B6 (cs) 2003-06-18
HU218910B (hu) 2000-12-28
EE9700208A (et) 1998-02-16
EP0769956B1 (de) 2000-03-15
BG63363B1 (bg) 2001-11-30
HU9700046D0 (en) 1997-02-28
EP0769956A1 (de) 1997-05-02
CA2195745A1 (en) 1996-02-08
AP9700913A0 (en) 1997-01-31
EE03515B1 (et) 2001-10-15
DK0769956T3 (da) 2000-06-05
RU2181598C2 (ru) 2002-04-27

Similar Documents

Publication Publication Date Title
GB9423910D0 (en) Therapeutic agents
GB9415997D0 (en) Therapeutic agents
GB9417310D0 (en) Therapeutic agents
GB9420168D0 (en) Therapeutic agents
GB9416189D0 (en) Therapeutic agents
GB9402641D0 (en) Therapeutic agents
GB9410031D0 (en) Therapeutic agents
GB9423460D0 (en) Therapeutic agents
EE03515B1 (et) GnRH antagonist kasutamiseks gonadaalsteroid-sõltuva seisundi ravis
GB9411955D0 (en) Therapeutic agents
GB9401879D0 (en) Therapeutic agents
GB9403639D0 (en) Therapeutic agents
HUP0003908A3 (en) Use of substituted azaspirane in the manufacture of a medicament for use in treating asthma
GB9402011D0 (en) Therapeutic agents
GB9324852D0 (en) A medicament for the treatment of metasteses
IL130103A0 (en) The use of a diarylalkane derivative in the manufacture of a medicament for treatment or prevention of pancreatitis
CA75178S (en) Medicament inhalation device
GB9810521D0 (en) Use of an agent in the manufacture of a medicament
ZA947352B (en) Therapeutic benzimidazoles
BG98003U (en) Medicament for the treatment of dermatomycosis
GB9410080D0 (en) Therapeutic agents
GB9415805D0 (en) Therapeutic agents
GB9410027D0 (en) Therapeutic agents
GB9411953D0 (en) Therapeutic agents
GB9408160D0 (en) Therapeutic agents

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees